HIV diagnoses among American Indians and Alaska Natives rose 70% from 2011 to 2016, according to data in the CDC's Morbidity and Mortality Weekly Report. The study found there is a need for greater mental health screening and peer support services among HIV-positive American Indians and Alaska Natives.
Containing the Ebola virus in the Democratic Republic of Congo will take at least six more months, according to World Health Organization Deputy Director-General Dr. Peter Salama. "Though this is the 10th outbreak in the DRC, this is a community and region that has never seen Ebola. There was no baseline knowledge among health care workers in the community about the disease," Salama said.
Dragonfly Therapeutics said it will spend $10 million to begin clinical studies of TriNKETs, or tri-specific, NK cell engager therapies, in hematological cancers and solid tumors. The trials will be performed in partnership with the University of Texas MD Anderson Cancer Center.
A study of data on almost 2,900 people in the UK with HFE C282Y mutations found that hemochromatosis was diagnosed in 10% of the women and almost 22% of the men. The results in The BMJ also indicated that those with mutations were at higher risk of premature death or developing serious health conditions as they got older, compared with people without the mutations.
An analysis of data from mass-casualty events found that public venues could save lives by stocking bleeding-control kits with supplies to treat 20 or more people, researchers reported in the American Journal of Public Health. The analysis included data about events such as mass shootings, intentional vehicle attacks and suicide bombings. "Bleeding control is a life skill that everyone should have," said Dr. Lenworth Jacobs of the University of Connecticut in Hartford, who directs the Stop the Bleed program and who was not involved in the study.
Two trials will use two different stem cell therapies to treat age-related macular degeneration. Embryo-derived stem cells will be tested in a Phase II study by researchers at the University of Southern California, while a National Eye Institute team will use a therapy derived from induced pluripotent stem cells.
Two late-stage studies reported in The New England Journal of Medicine found that GlaxoSmithKline's anti-malarial drug Krintafel, or tafenoquine, was associated with reduced rates of malaria relapse in patients with Plasmodium vivax. Decreases in hemoglobin were seen in some patients.
Health Network Laboratories has purchased Connective Tissue Gene Tests, which offers over 3,300 tests covering more than 1,000 genes, for an undisclosed amount. The deal will allow HNL to expand the reach of its molecular diagnostic testing services to include inherited genetic disorders.
Interpace Diagnostics signed a deal with the University of Maryland Medical System that will allow physicians across the UMMS network to use Interpace's ThyGeNEXT, ThyraMIR and PancraGEN tests. UMMS doctors can use the tests to evaluate indeterminate thyroid nodules and pancreatic cysts, and solid lesions.
- Page 1